Role of the PKA-regulated transcription factor CREB in development and tumorigenesis of endocrine tissues

Annals of the New York Academy of Sciences

Volumn 968, Issue , 2002, Pages 65-74

  Rosenberg, D ^a,c   Groussin, L ^a   Jullian, E ^a   Perlemoine, K ^a   Bertagna, X ^a,b   Bertherat, Jerome ^a,b  

^a CNRS   (France)

^b Ecole Nationale Vétérinaire d’Alfort ^*  (France)

^c ECOLE NATIONALE VÉTÉRINAIRE D ALFORT   (France)

Author keywords

cAMP; cAMP response element binding protein (CREB); Endocrine tumors; Protein kinase A (PKA)

Indexed keywords

CORTICOTROPIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GROWTH HORMONE; TRANSCRIPTION FACTOR;

ADENOMA; ALBRIGHT SYNDROME; CARCINOGENESIS; CELL PROLIFERATION; CONFERENCE PAPER; CUSHING SYNDROME; ENDOCRINE TUMOR; GENE MUTATION; GENE OVEREXPRESSION; HYPOPHYSIS CELL; MALIGNANT TRANSFORMATION; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TRANSCRIPTION REGULATION;

MUS MUSCULUS;

EID: 0036291366     PISSN: 00778923     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1749-6632.2002.tb04327.x     Document Type: Article

References (38)

1. Cyclic adenosine 3′,5′-monophosphate response element binding protein (CREB) and related transcription-activating deoxyribonucleic acid-binding proteins
2. Transcriptional regulation by the phosphorylation-dependent factor CREB
3. Developmental switch of CREM function during spermatogenesis: From antagonist to activator
4. Coupling gene expression to cAMP signalling: Role of CREB and CREM
5. Phosphorylated CREB binds specifically to the nuclear protein CBP
6. Multiple facets of the modulation of growth by cAMP
7. Impaired fetal T cell development and perinatal lethality in mice lacking the cAMP response element binding protein
8. Deficient long-term memory in mice with a targeted mutation of the cAMP-responsive element-binding protein
9. Defective thymocyte proliferation and IL-2 production in transgenic mice expressing a dominant-negative form of CREB
10. Somatotroph hypoplasia and dwarfism in transgenic mice expressing a non-phosphorylatable CREB mutant
11. 3′,5′-cyclic adenosine monophosphate-regulated enhancer binding (CREB) activity is required for normal growth and differentiated phenotype in the FRTL5 thyroid follicular cell line
12. A dominant negative CREB (cAMP response element-binding protein) isoform inhibits thyrocyte growth, thyroid-specific gene expression, differentiation, and function
13. Requirement for cAMP-response element (CRE) binding protein CRE modulator transcription factors in thyrotropin-induced proliferation of dog thyroid cells in primary culture
14. Adenovirus-directed expression of a nonphosphorylatable mutant of CREB (cAMP response element-binding protein) adversely affects the survival, but not the differentiation, of rat granulosa cells
15. Spermiogenesis deficiency and germ-cell apoptosis in CREM-mutant mice
16. Spermiogenesis requires the transcription factor CREM (cyclic AMP-response element modulator)
17. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas
18. Gastric inhibitory polypeptide-dependent cortisol hypersecretion - A new cause of Cushing's syndrome
19. Ectopic and abnormal hormone receptors in adrenal Cushing's syndrome
20. Food-dependent Cushing's syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory polypeptide
21. GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours
22. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome
23. The complex of myxomas, spotty pigmentation, and endocrine overactivity
24. Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the Carney complex
25. Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex
26. Mutations in the protein kinase A R1alpha regulatory subunit cause familial cardiac myxomas and Carney complex
27. The cyclic adenosine 3′,5′-monophosphate-responsive factor CREB is constitutively activated in human somatotroph adenomas
28. Genomic effects of the putative oncogene G alpha s. Chronic transcriptional activation of the c-fos proto-oncogene in endocrine cells
29. Transcriptional effects in GH3 cells of Gs alpha mutants associated with human pituitary tumors: Stimulation of adenosine 3′,5′-monophosphate response element-binding protein-mediated transcription and of prolactin and growth hormone promoter activity via protein kinase A
30. Constitutively active G(S) alpha-subunits stimulate Pit-1 promoter activity via a protein kinase A-mediated pathway acting through deoxyribonucleic acid binding sites both for Pit-1 and for adenosine 3′,5′-monophosphate response element-binding protein
31. Nuclear effects of the cAMP pathway activation in somatotrophs
32. Neuroendocrine regulation of growth hormone
33. Relevant cAMP-specific phosphodiesterase isoforms in human pituitary: Effect of Gs(alpha) mutations
34. Expression of cyclic adenosine 3′,5′-monophosphate (cAMP)-responsive element binding protein and inducible-cAMP early repressor genes in growth hormone-secreting pituitary adenomas with or without mutations of the Gsalpha gene
35. The NCI-H295 cell line: A pluripotent model for human adrenocortical studies
36. Transcriptional regulation of human 11beta-hydroxylase (hCYP11B1)
37. Loss of expression of the ubiquitous transcription factor cAMP response element-binding protein (CREB) and compensatory overexpression of the activator CREMτ in the human adrenocortical cancer cell line H295R
38. ACTH-receptor expression, regulation and role in adrenocortial tumor formation